Janus Henderson Group PLC Assembly Biosciences, Inc. Transaction History

Janus Henderson Group PLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 18, 2020	SELL	$8.36 - $23.81 $7.58 Million - $21.6 Million	-906,748 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$9.83 - $14.82 $490,379 - $739,310	-49,886 Reduced 5.21%	906,748 $8.91 Million
Q2 2019 Jul 31, 2019	BUY	$12.9 - $20.8 $48,362 - $77,979	3,749 Added 0.39%	956,634 $12.9 Million
Q1 2019 Apr 30, 2019	SELL	$17.7 - $24.93 $25,063 - $35,300	-1,416 Reduced 0.15%	952,885 $18.8 Million
Q4 2018 Feb 06, 2019	BUY	$19.05 - $36.45 $1.18 Million - $2.26 Million	62,096 Added 6.96%	954,301 $21.6 Million
Q3 2018 Nov 09, 2018	BUY	$34.41 - $44.23 $2.99 Million - $3.84 Million	86,780 Added 10.77%	892,205 $33.1 Million
Q2 2018 Aug 10, 2018	BUY	$39.21 - $50.29 $9.55 Million - $12.2 Million	243,582 Added 43.35%	805,425 $31.6 Million
Q1 2018 May 14, 2018	BUY	$41.7 - $64.16 $23.4 Million - $36 Million	561,843 New	561,843 $27.6 Million

16.3K

Ticker ASMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,436,900
Market Cap $822M
Description
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

Stay updated on Janus Henderson Group PLC with notifications on news.